Norma Schafer Email

VP Regulatory Affairs . Rénibus Therapeutics

Current Roles

Employees:
38
Revenue:
$3.8M
About
Rénibus Therapeutics is a clinical-stage biotech company dedicated to transforming the cardiorenal disease treatment paradigm by focusing on the prevention and treatment of kidney disease. The company’s portfolio includes RBT-1 for prevention of acute kidney injury, RBT-2 for treatment of chronic kidney disease, and RBT-3 for treatment of iron deficiency anemia and platinum-based kidney toxicity.
Rénibus Therapeutics Address
181 Grand Ave
Southlake, TX
Rénibus Therapeutics Email

Past Companies

Rénibus Therapeutics IncVice President Regulatory Affairs
San Diego State UniversityRegulatory Affairs Instructor
Urgo Medical North America, formerly SteadMed MedicalVice President of Regulatory Affairs and Quality Assurance

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.